Overall rank by patents
#2,136
Across all tracked assignees
USPTO PatentsView assignee record - 185 granted patents across 42 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A62B (DEVICES, APPARATUS OR METHODS FOR LIFE-SAVING).
The verdict
Zedel holds 185 US patents across 42 technology areas, rank #2,136 of 50,000 tracked assignees.
Zedel has been granted 185 US utility patents between 2015 and 2025, placing Zedel at rank #2,136 across all assignees tracked by PlainPatent. This portfolio spans 42 distinct Cooperative Patent Classification (CPC) subclasses, averaging 5.4 claims per patent with primary concentration in A62B (DEVICES, APPARATUS OR METHODS FOR LIFE-SAVING). As a Foreign Corporation, Zedel is one of the more focused assignees in the PatentsView dataset. By volume, Zedel sits between Petróleo Brasileiro S.a.—petrobras (185 patents, rank #2,132) and ETH Zurich (184 patents, rank #2,140) - the closest US assignees by grant volume. The composite Innovation Score of 51.2/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 101 grants, compared with 84 in the 2015–2019 window, a +20% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Zedel's 5.4 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while a multi-domain presence across 42 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Zedel against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
PETRÓLEO BRASILEIRO S.A.—PETROBRAS
185 patents
PROTERIAL, LTD.
185 patents
PerkinElmer Health Sciences, Inc.
185 patents
RAYTHEON BBN TECHNOLOGIES CORP.
185 patents
ZEDEL
185 patents
ASICS CORPORATION
184 patents
Adtran, Inc.
184 patents
Dart Industries Inc.
184 patents
ETH ZURICH
184 patents
What this shows Zedel holds 185 patents at rank #2,136, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #2,136 in granted patent volume.
Other assignees with the most granted patents in Zedel's primary technology class.
Zedel's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
51 Top 12% higher than 88% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 21 | 11.4% |
| 2016 | 23 | 12.4% |
| 2017 | 11 | 5.9% |
| 2018 | 14 | 7.6% |
| 2019 | 15 | 8.1% |
| 2020 | 21 | 11.4% |
| 2021 | 10 | 5.4% |
| 2022 | 13 | 7.0% |
| 2023 | 18 | 9.7% |
| 2024 | 17 | 9.2% |
| 2025 | 22 | 11.9% |
Top 15 of 42 technology areas
Overall rank by patents
#2,136
Across all tracked assignees
51.2 out of 100
How to use this portfolio
Zedel's 185 grants land it in the top 12% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.